Methods for corticosteroid withdrawal: Adrenal insufficiency: identification and management
- PMID: 39541482
- Bookshelf ID: NBK609099
Methods for corticosteroid withdrawal: Adrenal insufficiency: identification and management
Excerpt
Exogenous glucocorticoids are used for their anti-inflammatory and immunosuppressive properties across many conditions ranging from asthma, inflammatory bowel disease, polymyalgia rheumatica and organ transplantation.
Mild symptoms during withdrawal of exogenous glucocorticoids are an expected and common occurrence and generally do not indicate unmasked adrenal insufficiency. However, if there is underlying adrenal insufficiency, either owing to adrenal suppression or because of medication use or intrinsic pituitary/adrenal disease it is potentially life-threatening. The risk of adrenal suppression depends on the dose and duration of the exogenous steroid therapy, as well as individual factors.
Current practice is very variable. Some clinicians gradually reduce the exogenous glucocorticoid dose over months, to a lower than physiological dose, and then provided that the patient feels well on the low daily dose this is simply stopped. Other clinicians will perform testing to check for adequate adrenal function before stopping glucocorticoids.
This evidence review considers what is the best way to manage glucocorticoid withdrawal when glucocorticoids are no longer needed to control underlying disease activity.
Copyright © NICE 2024.
Similar articles
-
When to refer for specialist investigation when withdrawing corticosteroids: Adrenal insufficiency: identification and management: Evidence review C.London: National Institute for Health and Care Excellence (NICE); 2024 Aug. London: National Institute for Health and Care Excellence (NICE); 2024 Aug. PMID: 39541483 Free Books & Documents. Review.
-
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247. Zhonghua Jie He He Hu Xi Za Zhi. 2024. PMID: 38309959 Chinese.
-
Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.Cochrane Database Syst Rev. 2020 Mar 19;3(3):CD012517. doi: 10.1002/14651858.CD012517.pub2. Cochrane Database Syst Rev. 2020. PMID: 32190901 Free PMC article.
-
Glucocorticoid induced adrenal insufficiency.BMJ. 2021 Jul 12;374:n1380. doi: 10.1136/bmj.n1380. BMJ. 2021. PMID: 34253540 Review.
-
Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself.Eur J Intern Med. 2013 Dec;24(8):714-20. doi: 10.1016/j.ejim.2013.05.014. Epub 2013 Jun 25. Eur J Intern Med. 2013. PMID: 23806261 Review.
Publication types
LinkOut - more resources
Full Text Sources